Analyzing the Scope and Claims of United States Patent 11,286,486: A Comprehensive Guide
Introduction
Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article delves into the details of United States Patent 11,286,486, focusing on its claims, scope, and the broader patent landscape.
Overview of the Patent
Patent Number and Title
United States Patent 11,286,486, titled "Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases," is a significant development in the field of genetic therapies.
Publication and Priority Dates
The patent was published on October 25, 2022, with a priority date that traces back to the original filing of the patent application[4].
Claims Analysis
Independent and Dependent Claims
The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations.
- Independent Claims: These claims outline the core invention, such as the composition of iRNA agents targeting the transthyretin (TTR) gene and methods for their use in treating or preventing TTR-associated diseases.
- Dependent Claims: These claims build upon the independent claims by specifying particular aspects, such as the structure of the iRNA agents, the delivery methods, and the specific diseases targeted[4].
Claim Language and Scope
The scope of the patent is defined by the language used in the claims. For example, the patent claims cover "double-stranded iRNA agents" that target the TTR gene. This specificity is crucial in determining the breadth of protection afforded by the patent.
- Independent Claim Length and Count: Research suggests that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process[3].
Patent Scope and Validity
Presumption of Validity
Each claim of the patent is presumed valid independently of the validity of other claims, as per 35 USC 282. This presumption can be challenged during litigation, but it provides a strong foundation for the patent's enforceability[5].
Breadth of Protection
The patent's scope is not overly broad, as it is narrowly tailored to specific iRNA compositions and their methods of use. This specificity helps in avoiding potential issues of patent quality, such as decreased clarity and questionable validity[3].
Examination Process
Narrowing of Claims
During the examination process, the claims may be narrowed to address any issues raised by the patent office. This narrowing can result in a more focused and defensible patent. For US Patent 11,286,486, the examination process likely involved negotiations between the applicant and the USPTO to ensure the claims were clear, novel, and non-obvious[3].
International and Global Context
Global Dossier
For patents with international implications, tools like the Global Dossier can be invaluable. This service provides access to the file histories of related applications from participating IP Offices, helping to identify the global patent family and any office actions[1].
International Patent Offices
To ensure that the invention is not already patented abroad, searching international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) is essential[1].
Practical Implications
Licensing and Litigation
The clarity and specificity of the claims in US Patent 11,286,486 can reduce licensing and litigation costs. Clear claims help in avoiding disputes over the scope of the invention, thereby fostering a more stable and predictable intellectual property environment[3].
Innovation Incentives
By providing a clear and defensible scope, the patent encourages innovation. Inventors and companies are more likely to invest in research and development when they have a clear understanding of what is protected and what is not[3].
Conclusion
Understanding the scope and claims of US Patent 11,286,486 is crucial for anyone involved in genetic therapies or related fields. The patent's specific claims, the presumption of validity, and the global context all contribute to a robust intellectual property strategy.
Key Takeaways
- Specific Claims: The patent includes specific claims about iRNA compositions and their methods of use.
- Presumption of Validity: Each claim is presumed valid independently.
- Narrowing of Claims: The examination process likely narrowed the claims to ensure clarity and defensibility.
- Global Context: Tools like the Global Dossier and international patent databases are essential for understanding the global patent landscape.
- Practical Implications: Clear claims reduce licensing and litigation costs and encourage innovation.
FAQs
What is the main subject of US Patent 11,286,486?
The main subject of US Patent 11,286,486 is the composition of iRNA agents targeting the transthyretin (TTR) gene and methods for their use in treating or preventing TTR-associated diseases.
How are the claims in this patent structured?
The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims add additional limitations.
What is the significance of the presumption of validity in patent law?
Each claim of a patent is presumed valid independently of the validity of other claims, providing a strong foundation for the patent's enforceability.
How does the examination process affect the scope of patent claims?
The examination process can narrow the scope of patent claims to address any issues raised by the patent office, resulting in a more focused and defensible patent.
What tools can be used to understand the global patent landscape for this invention?
Tools like the Global Dossier and international patent databases such as those provided by the EPO, JPO, and WIPO can be used to understand the global patent landscape.
Sources
- USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
- ACUS - U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court
- SSRN - Patent Claims and Patent Scope. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
- Google Patents - US11286486B2. Retrieved from https://patents.google.com/patent/US11286486B2/en
- US Code - 35 USC 282. Retrieved from https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-1994-title35-section282&num=0&edition=1994
